Literature DB >> 6859660

Macrophage function in pulmonary alveolar proteinosis.

K M Nugent, E L Pesanti.   

Abstract

We studied the lavage fluid recovered from a symptomatic patient with pulmonary alveolar proteinosis using in vitro assays for macrophage function. The alveolar macrophages from this patient had reduced phagocytic capacity. The particulate fraction from the cell-free lavage fluid (20,000 X gravity pellet) induced a pronounced phagocytic defect in normal mouse peritoneal macrophages but did not impair intracellular degradative activity. These results suggest that the lipoproteinaceous debris in patients with alveolar proteinosis can induce a phagocytic defect in alveolar macrophages, which probably increases the accumulation of more debris and may contribute to the increased risk of pulmonary infection.

Entities:  

Mesh:

Year:  1983        PMID: 6859660     DOI: 10.1164/arrd.1983.127.6.780

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  9 in total

Review 1.  Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis.

Authors:  P L Shah; D Hansell; P R Lawson; K B Reid; C Morgan
Journal:  Thorax       Date:  2000-01       Impact factor: 9.139

Review 2.  The role of surfactant in the pulmonary reaction to mineral particles.

Authors:  A G Heppleston
Journal:  Int J Exp Pathol       Date:  1991-10       Impact factor: 1.925

3.  GM-CSF regulates a PU.1-dependent transcriptional program determining the pulmonary response to LPS.

Authors:  Pierre-Yves Berclaz; Brenna Carey; Marie-Dominique Fillipi; Kara Wernke-Dollries; Nick Geraci; Stephanie Cush; Terry Richardson; Joe Kitzmiller; Michael O'connor; Christina Hermoyian; Thomas Korfhagen; Jeffrey A Whitsett; Bruce C Trapnell
Journal:  Am J Respir Cell Mol Biol       Date:  2006-08-17       Impact factor: 6.914

Review 4.  Secondary alveolar proteinosis in cancer patients.

Authors:  S Ladeb; J Fleury-Feith; E Escudier; J Tran Van Nhieu; J F Bernaudin; C Cordonnier
Journal:  Support Care Cancer       Date:  1996-11       Impact factor: 3.603

5.  Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression.

Authors:  U Dirksen; R Nishinakamura; P Groneck; U Hattenhorst; L Nogee; R Murray; S Burdach
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

Review 6.  Alveolar proteinosis and nocardiosis: a patient treated by bronchopulmonary lavage.

Authors:  J Pascual; M A Gómez Aguinaga; R Vidal; A Maudes; A Sureda; E Gómez Mampaso; L Fogué
Journal:  Postgrad Med J       Date:  1989-09       Impact factor: 2.401

7.  Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor.

Authors:  T Kitamura; N Tanaka; J Watanabe; S Kanegasaki; Y Yamada; K Nakata
Journal:  J Exp Med       Date:  1999-09-20       Impact factor: 14.307

8.  Pulmonary Alveolar Proteinosis Due to Pneumocystis carinii in Type 1 Hyper-IgM Syndrome: A Case Report.

Authors:  Fei Zhou Zhang; Jie Xin Yuan; Lu Qin; Lan Fang Tang
Journal:  Front Pediatr       Date:  2020-06-11       Impact factor: 3.418

9.  Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF.

Authors:  Martin Guilliams; Ismé De Kleer; Sandrine Henri; Sijranke Post; Leen Vanhoutte; Sofie De Prijck; Kim Deswarte; Bernard Malissen; Hamida Hammad; Bart N Lambrecht
Journal:  J Exp Med       Date:  2013-09-16       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.